Comparative Study
doi: 10.1128/AAC.31.2.340.
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci
- PMID: 3032099
- PMCID: PMC174722
- DOI: 10.1128/AAC.31.2.340
Item in Clipboard
Comparative Study
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci
Antimicrob Agents Chemother.
1987 Feb.
Abstract
The activity of LY146032, a new lipopeptide antibiotic, was compared in vitro with those of vancomycin, oxacillin, and ampicillin against 261 staphylococcal and 154 streptococcal isolates. The MICs of LY146032 and vancomycin were similar, but the bactericidal activity and killing kinetics of LY146032 were more pronounced.
Similar articles
-
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.Eur J Clin Microbiol. 1987 Feb;6(1):100-3. doi: 10.1007/BF02097211. Eur J Clin Microbiol. 1987. PMID: 3032607
-
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.Eur J Clin Microbiol. 1987 Feb;6(1):96-9. doi: 10.1007/BF02097210. Eur J Clin Microbiol. 1987. PMID: 3032613
-
In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.Eur J Clin Microbiol. 1987 Feb;6(1):91-6. doi: 10.1007/BF02097209. Eur J Clin Microbiol. 1987. PMID: 3032612
-
Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.Antimicrob Agents Chemother. 1986 Dec;30(6):938-9. doi: 10.1128/AAC.30.6.938. Antimicrob Agents Chemother. 1986. PMID: 3028254 Free PMC article.
-
Therapeutic update on glycopeptide and lipopeptide antibiotics.Pharmacotherapy. 1988;8(4):211-9. doi: 10.1002/j.1875-9114.1988.tb04076.x. Pharmacotherapy. 1988. PMID: 2848228 Review.
Cited by
-
Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae.Antimicrob Agents Chemother. 1995 Sep;39(9):2068-72. doi: 10.1128/AAC.39.9.2068. Antimicrob Agents Chemother. 1995. PMID: 8540717 Free PMC article.
-
In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria.Antimicrob Agents Chemother. 1988 May;32(5):788-90. doi: 10.1128/AAC.32.5.788. Antimicrob Agents Chemother. 1988. PMID: 2840019 Free PMC article.
-
Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model.Antimicrob Agents Chemother. 1990 Oct;34(10):1925-31. doi: 10.1128/AAC.34.10.1925. Antimicrob Agents Chemother. 1990. PMID: 1963288 Free PMC article.
-
Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.Antimicrob Agents Chemother. 1989 Oct;33(10):1783-90. doi: 10.1128/AAC.33.10.1783. Antimicrob Agents Chemother. 1989. PMID: 2556079 Free PMC article. Clinical Trial.
-
Activity of LY146032 against Enterococci with and without high-level aminoglycoside resistance, including two penicillinase-producing strains.Antimicrob Agents Chemother. 1987 Nov;31(11):1779-81. doi: 10.1128/AAC.31.11.1779. Antimicrob Agents Chemother. 1987. PMID: 2829715 Free PMC article.
References
-
- Antimicrob Agents Chemother. 1985 Mar;27(3):357-62 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
